Dosing
- COVID-19: Nirmatrelvir/ritonavir 300 mg/100 mg p.o. bid for 5 days, started within 5 days of symptom onset
Renal Dosing
- eGFR ≥60 mL/min: no adjustment
- eGFR 30-59 mL/min: nirmetrelvir/ritonavir 150 mg/100 mg p.o. bid
- eGFR <30 mL/min: not recommended
